Cargando…
The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer
The majority of breast cancers are oestrogen receptor-positive (ER+). In ER+ cancers, oestrogen acts as a disease driver, so these tumours are likely to be susceptible to endocrine therapy (ET). ET works by blocking the hormone’s synthesis or effect. A significant number of patients diagnosed with b...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608445/ https://www.ncbi.nlm.nih.gov/pubmed/37888087 http://dx.doi.org/10.3390/jpm13101476 |
_version_ | 1785127782041255936 |
---|---|
author | Kay, Charlene Martinez-Perez, Carlos Dixon, J. Michael Turnbull, Arran K. |
author_facet | Kay, Charlene Martinez-Perez, Carlos Dixon, J. Michael Turnbull, Arran K. |
author_sort | Kay, Charlene |
collection | PubMed |
description | The majority of breast cancers are oestrogen receptor-positive (ER+). In ER+ cancers, oestrogen acts as a disease driver, so these tumours are likely to be susceptible to endocrine therapy (ET). ET works by blocking the hormone’s synthesis or effect. A significant number of patients diagnosed with breast cancer will have the spread of tumour cells into regional lymph nodes either at the time of diagnosis, or as a recurrence some years later. Patients with node-positive disease have a poorer prognosis and can respond less well to ET. The nodal metastases may be genomically similar or, as is becoming more evident, may differ from the primary tumour. However, nodal metastatic disease is often not assessed, and treatment decisions are almost always based on biomarkers evaluated in the primary tumour. This review will summarise the evidence in the field on ER+, node-positive breast cancer, including diagnosis, treatment, prognosis and predictive tools. |
format | Online Article Text |
id | pubmed-10608445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106084452023-10-28 The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer Kay, Charlene Martinez-Perez, Carlos Dixon, J. Michael Turnbull, Arran K. J Pers Med Review The majority of breast cancers are oestrogen receptor-positive (ER+). In ER+ cancers, oestrogen acts as a disease driver, so these tumours are likely to be susceptible to endocrine therapy (ET). ET works by blocking the hormone’s synthesis or effect. A significant number of patients diagnosed with breast cancer will have the spread of tumour cells into regional lymph nodes either at the time of diagnosis, or as a recurrence some years later. Patients with node-positive disease have a poorer prognosis and can respond less well to ET. The nodal metastases may be genomically similar or, as is becoming more evident, may differ from the primary tumour. However, nodal metastatic disease is often not assessed, and treatment decisions are almost always based on biomarkers evaluated in the primary tumour. This review will summarise the evidence in the field on ER+, node-positive breast cancer, including diagnosis, treatment, prognosis and predictive tools. MDPI 2023-10-08 /pmc/articles/PMC10608445/ /pubmed/37888087 http://dx.doi.org/10.3390/jpm13101476 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kay, Charlene Martinez-Perez, Carlos Dixon, J. Michael Turnbull, Arran K. The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer |
title | The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer |
title_full | The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer |
title_fullStr | The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer |
title_full_unstemmed | The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer |
title_short | The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer |
title_sort | role of nodes and nodal assessment in diagnosis, treatment and prediction in er+, node-positive breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608445/ https://www.ncbi.nlm.nih.gov/pubmed/37888087 http://dx.doi.org/10.3390/jpm13101476 |
work_keys_str_mv | AT kaycharlene theroleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT martinezperezcarlos theroleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT dixonjmichael theroleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT turnbullarrank theroleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT kaycharlene roleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT martinezperezcarlos roleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT dixonjmichael roleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer AT turnbullarrank roleofnodesandnodalassessmentindiagnosistreatmentandpredictioninernodepositivebreastcancer |